The popularity of Sildenafil initially sparked a period of growth for pharma, nevertheless recent shifts present a murky picture for shareholders. Generic competitors are eating into profits, and persistent litigation https://rishiuyta394171.rimmablog.com/39934498/viagra-and-pharma-a-precarious-play